By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Nextgen Biomed Ltd (NXGN.TA)

TLV Market Data in ILA, Fundamentals in ILS
ILA 55.50
-ILA 5.10
-8.42%
Last Update: 14 Sept 2025, 12:53
ILA 6.41M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
ILA 45.60 - ILA 86.00
52 Week Range

NXGN.TA Stock Price Chart

Explore Nextgen Biomed Ltd interactive price chart. Choose custom timeframes to analyze NXGN.TA price movements and trends.

NXGN.TA Company Profile

Discover essential business fundamentals and corporate details for Nextgen Biomed Ltd (NXGN.TA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

12 Aug 2002

Employees

3.00

CEO

Harel Hershtik

Description

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

NXGN.TA Financial Timeline

Browse a chronological timeline of Nextgen Biomed Ltd corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 3 Sept 2023

Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 9 Jul 2023

Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Mar 2021

NXGN.TA Stock Performance

Access detailed NXGN.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run